Skip to main content

Find Clinical Trials

Home
Conditions
Solid Tumor

Clinical trial condition

Solid Tumor

Explore clinical trials studying Solid Tumor. Study availability and eligibility vary by location and protocol.

729 public trials 250 recruiting studies

Refine in advanced search Browse all conditions

Solid Tumor trial results

Completed

A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies

NCT00840190

Conditions: Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +4 more
Locations: Tata Memorial Centre Mumbai, Maharashtra, India

Ruby Hall Clinic Pune, Maharashtra, India

Jehangir Hospital Pune, Maharashtra, India

SEAROC Cancer Centre, Jaipur, Rajasthan, India

View Trial Details

Completed

Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype

NCT00808184

Conditions: Solid Tumor
Locations: National University Hospital Singapore

Tan Tock Seng Hospital Singapore

View Trial Details

Completed

Pain Control in Hospice Patients With Cancer-Related Pain

NCT00609297

Conditions: Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Family Quality of Life Among Families With a Member Who is a Cancer Patient

NCT00544336

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +58 more
Locations: Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies

NCT01041235

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +28 more
Locations: Mary Crowley Cancer Research Centers (MCCRC) Dallas, Texas, United States

Cancer Therapy and Research Center (CTRC) San Antonio, Texas, United States

View Trial Details

Completed

Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients

NCT00483457

Conditions: Solid Tumor
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Study of CEP-9722 as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanced Solid Tumors

NCT00920595

Conditions: Neoplasms, Solid Tumor
Locations: Cephalon Investigational Site Nantes, France

Cephalon Investigational Site Newcastle upon Tyne, United Kingdom

View Trial Details

Completed

Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies

NCT00251407

Conditions: Solid Tumor
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer

NCT00888108

Conditions: Solid Tumor
Locations: Site Reference ID/Investigator# 51982 Scottsdale, Arizona, United States

Site Reference ID/Investigator# 44182 Fort Lauderdale, Florida, United States

Site Reference ID/Investigator# 43962 Baltimore, Maryland, United States

Site Reference ID/Investigator# 12844 Rotterdam, Netherlands

View Trial Details

Completed

A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours

NCT00737555

Conditions: Neoplasms, Solid Tumor
Locations: UMC St Radboud Nijmegen, Netherlands

Erasmus MC University Medical Centre- Location Centrum Rotterdam, Netherlands

View Trial Details